STACEY BERG to Cyclin-Dependent Kinase 4
This is a "connection" page, showing publications STACEY BERG has written about Cyclin-Dependent Kinase 4.
Connection Strength
0.291
-
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I). JCO Precis Oncol. 2024 Sep; 8:e2400418.
Score: 0.233
-
Cyclin D and cisplatin cytotoxicity in primary neuroblastoma cell lines. Anticancer Drugs. 2004 Oct; 15(9):883-8.
Score: 0.059